Baird Downgrades Aprea (APRE) to Neutral on Trial Failure
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts APRE Hot Sheet
Price: $0.51 -1.92%
Rating Summary:
5 Buy, 3 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 16 | Down: 25 | New: 12
Rating Summary:
5 Buy, 3 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 16 | Down: 25 | New: 12
Join SI Premium – FREE
Baird analyst Madhu Kumar downgraded Aprea (NASDAQ: APRE) from Outperform to Neutral with a price target of $5.00 (from $45.00).
For an analyst ratings summary and ratings history on Aprea click here. For more ratings news on Aprea click here.
Shares of Aprea closed at $25.09 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AMD (AMD) PT Raised to $600 at DA Davidson
- Revvity Inc (RVTY) PT Raised to $177 at Stifel
- People Incorporated (PPLI) PT Lowered to $58 at StoneX
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesRelated Entities
Robert W BairdSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
